OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies
Ruiyuan Xu, Jinshou Yang, Bo Ren, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 58
Ruiyuan Xu, Jinshou Yang, Bo Ren, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 58
Showing 26-50 of 58 citing articles:
Promising Therapeutic Approach in Pancreatic Cancer: Metabolism-Related Genes
Soohyun Choe, Woori Kwak, E. Kim, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 4, pp. 137-137
Open Access | Times Cited: 2
Soohyun Choe, Woori Kwak, E. Kim, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 4, pp. 137-137
Open Access | Times Cited: 2
Multi-omics reveals bufadienolide Q-markers of Bufonis Venenum based on antitumor activity and cardiovascular toxicity in zebrafish
Bo Sun, Nan Si, Xiaolu Wei, et al.
Phytomedicine (2024) Vol. 133, pp. 155914-155914
Closed Access | Times Cited: 2
Bo Sun, Nan Si, Xiaolu Wei, et al.
Phytomedicine (2024) Vol. 133, pp. 155914-155914
Closed Access | Times Cited: 2
Uncovering metabolic signatures in cancer-derived exosomes: LC-MS/MS and NMR profiling
Nandini Bajaj, Deepika Sharma
Nanoscale (2024)
Closed Access | Times Cited: 2
Nandini Bajaj, Deepika Sharma
Nanoscale (2024)
Closed Access | Times Cited: 2
The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways
Chao Yin, Ali Alqahtani, Marcus Smith Noel
Cancers (2022) Vol. 14, Iss. 11, pp. 2619-2619
Open Access | Times Cited: 11
Chao Yin, Ali Alqahtani, Marcus Smith Noel
Cancers (2022) Vol. 14, Iss. 11, pp. 2619-2619
Open Access | Times Cited: 11
Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer
Chen Liu, Shengming Deng, Zhiwen Xiao, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Chen Liu, Shengming Deng, Zhiwen Xiao, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer
Hayato Muranaka, Andrew Hendifar, Arsen Osipov, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 3020-3020
Open Access | Times Cited: 6
Hayato Muranaka, Andrew Hendifar, Arsen Osipov, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 3020-3020
Open Access | Times Cited: 6
Construction of miRNA‐lncRNA‐mRNA co‐expression network affecting EMT‐ mediated cisplatin resistance in ovarian cancer
Amirhossein Naghsh Nilchi, Laleh Ebrahimi Ghahnavieh, Fariba Dehghanian
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 16, pp. 4530-4547
Open Access | Times Cited: 10
Amirhossein Naghsh Nilchi, Laleh Ebrahimi Ghahnavieh, Fariba Dehghanian
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 16, pp. 4530-4547
Open Access | Times Cited: 10
Therapeutic Aspects and Molecular Targets of Autophagy to Control Pancreatic Cancer Management
Md. Ataur Rahman, Kazi Rejvee Ahmed, MD. Hasanur Rahman, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1459-1459
Open Access | Times Cited: 9
Md. Ataur Rahman, Kazi Rejvee Ahmed, MD. Hasanur Rahman, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1459-1459
Open Access | Times Cited: 9
TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC
Meena Rajagopal, Shivani Bansal, Prabhjit Kaur, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6204-6204
Open Access | Times Cited: 12
Meena Rajagopal, Shivani Bansal, Prabhjit Kaur, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6204-6204
Open Access | Times Cited: 12
Differential Effects of Dietary Macronutrients on the Development of Oncogenic KRAS-Mediated Pancreatic Ductal Adenocarcinoma
Liang Zhu, Jun‐Tao Ji, Jianjia Ma, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2723-2723
Open Access | Times Cited: 9
Liang Zhu, Jun‐Tao Ji, Jianjia Ma, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2723-2723
Open Access | Times Cited: 9
Pancreatic ductal adenocarcinoma: Emerging therapeutic strategies
Daniel Osei‐Bordom, Nikolaos Serifis, Zachary J. Brown, et al.
Surgical Oncology (2022) Vol. 43, pp. 101803-101803
Closed Access | Times Cited: 8
Daniel Osei‐Bordom, Nikolaos Serifis, Zachary J. Brown, et al.
Surgical Oncology (2022) Vol. 43, pp. 101803-101803
Closed Access | Times Cited: 8
Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma
Ahmad H. Ali, Ugo Chianese, Chiara Papulino, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3799-3799
Open Access | Times Cited: 8
Ahmad H. Ali, Ugo Chianese, Chiara Papulino, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3799-3799
Open Access | Times Cited: 8
A Prognostic Survival Model of Pancreatic Adenocarcinoma Based on Metabolism-Related Gene Expression
Linying Xie, Hanying Huang, Tian Fang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 7
Linying Xie, Hanying Huang, Tian Fang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 7
Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer
Chang Liu, Henan Qin, Huiying Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Chang Liu, Henan Qin, Huiying Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Metabolism and structure of PDA as the target for new therapies: possibilities and limitations for nanotechnology
Adrianna Zygmunt, Jerzy Gubernator
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 6, pp. 845-865
Closed Access | Times Cited: 1
Adrianna Zygmunt, Jerzy Gubernator
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 6, pp. 845-865
Closed Access | Times Cited: 1
Research advances in branched-chain amino acid metabolism in tumors
Zheng Li, Sainan Chen, Xiaoyan Wu, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 1
Zheng Li, Sainan Chen, Xiaoyan Wu, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 1
Amino Acid Metabolic Vulnerabilities in Acute and Chronic Myeloid Leukemias
Aboli Bhingarkar, Hima V. Vangapandu, Sanjay Rathod, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 9
Aboli Bhingarkar, Hima V. Vangapandu, Sanjay Rathod, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 9
The Role and Mechanism of Autophagy in Pancreatic Cancer: An Update Review
Jian Ma, Huan Xue, Lihong He, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 8231-8240
Open Access | Times Cited: 7
Jian Ma, Huan Xue, Lihong He, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 8231-8240
Open Access | Times Cited: 7
Metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant Kras mouse model
Tatiana J. Carneiro, Joana Pinto, Eva M. Serrao, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 3
Tatiana J. Carneiro, Joana Pinto, Eva M. Serrao, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 3
Prognostic signature construction of energy metabolism-related genes in pancreatic cancer
Hao Liu, Jianhua Zhang, Chaoguang Wei, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Hao Liu, Jianhua Zhang, Chaoguang Wei, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
The Prognostic Role of Serine Racemase in Patients With Pancreatic Cancer
Chuan Lan, Yo‐ichi Yamashita, Masayo Tsukamoto, et al.
Pancreas (2023) Vol. 52, Iss. 2, pp. e101-e109
Closed Access | Times Cited: 1
Chuan Lan, Yo‐ichi Yamashita, Masayo Tsukamoto, et al.
Pancreas (2023) Vol. 52, Iss. 2, pp. e101-e109
Closed Access | Times Cited: 1
How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy
Ya-Chu Tang, Yung‐Jen Chuang, Hsin-Huei Chang, et al.
Journal of Food and Drug Analysis (2023) Vol. 31, Iss. 3, pp. 387-407
Open Access | Times Cited: 1
Ya-Chu Tang, Yung‐Jen Chuang, Hsin-Huei Chang, et al.
Journal of Food and Drug Analysis (2023) Vol. 31, Iss. 3, pp. 387-407
Open Access | Times Cited: 1
Molecular biomarkers in pancreatic ductal adenocarcinoma
Junya Tsuboi, Reiko Yamada, Yoshifumi Hirokawa
Elsevier eBooks (2024), pp. 151-173
Closed Access
Junya Tsuboi, Reiko Yamada, Yoshifumi Hirokawa
Elsevier eBooks (2024), pp. 151-173
Closed Access
L-type Amino Acid Transporter 1 as a Therapeutic Target in Pancreatic Cancer
Ragnar Norrsell, Monika Bauden, Roland Andersson, et al.
Cancer Control (2024) Vol. 31
Open Access
Ragnar Norrsell, Monika Bauden, Roland Andersson, et al.
Cancer Control (2024) Vol. 31
Open Access
Deciphering the molecular mechanism of long non-coding RNA HIF1A-AS1 regulating pancreatic cancer cells
Jiaxin Zhang, Yifeng Sun, Jiahui Ma, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 6, pp. 3367-3377
Open Access
Jiaxin Zhang, Yifeng Sun, Jiahui Ma, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 6, pp. 3367-3377
Open Access
